Global Oncology Trends 2018 – Innovation, Expansion and Disruption

About the Report

Cancer treatments have been advancing at an accelerated pace in recent years, offering notable improvements in clinical benefit to patients. This report highlights advances in cancer therapeutics, including the use of these drugs and their global spending trends, the pipeline of therapeutic innovation and associated clinical trial activity, and the outlook through 2022. The report aims to provide an evidence base that can be used in discussion about the broader implications for cancer patients and their families, providers and their institutions, public and private payers at the local and national level, as well as multinational organizations.

Report Summary

The number of approved cancer therapies continues to rise, with 63 cancer drugs launching within the past five years. The continued rise and impact of immuno-oncology has been largely centered on the PD-1 and PD-L1 checkpoint inhibitors, which have broad efficacy across solid tumors and are used across 23 different tumor types. Of the 14 New Active Substance cancer therapeutics launched in 2017 alone, all of them were targeted therapies and 11 of them were granted Breakthrough Therapy designations by the FDA.

Source: https://www.iqvia.com/institute/reports/global-oncology-trends-2018

Related Post

Collaboration work with Scripps and Hebrew Univers...
views 532
Biocon collaborated with Dr. Min Guo (Scripps), and Dr. Ehud Razin (Hebrew University) to investigate KRS. They together published an article about KR...
전염병 치료 타겟으로의 ARS, Biochemical Pharmacology Mini Re...
views 754
  Biocon 세부 과제 책임자이신 한국생명공학연구원 김명희 박사님(사진 왼쪽)과 김성훈 단장님이 작업한 Mini Review 논문이 Biochemical Pharmacology에 발표 되었습니다. 논문 제목은 "Aminoacyl-tRNA ...
이진영 박사과정, AARS 2013 Oral Presentation Award 수상...
views 522
연구단 이진영 박사과정 학생이 10월 6일~11일 일본 하코네에서 열린 AARS 2013에서 Oral Presentation Award를 수상하였습니다.발표 제목은 Methionyl-tRNA Synthetase-mediated Misacylation as a ...
Min Youn Park (in the Ph.D program) was awarded Yo...
views 668
In 2012 KHUPO (held by SNU), Min Young Park (in the Ph.D. program) was awarded Young Scientist award. He presented a poster about "Quantitative proteo...

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2019 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar